Search | Search by Center | Search by Source | Keywords in Title
Layden J, Cao L, Corcoran P, Weaver FM, Uprichard S. Blocking the HCV entry factor NPC1L1 via ezetimibe improves HCV Outcomes. Paper presented at: International Symposium on HCV and Related Viruses; 2013 Oct 8; Melbourne, Australia.